Cargando…
c‐Myb promotes growth and metastasis of colorectal cancer through c‐fos‐induced epithelial‐mesenchymal transition
c‐Myb is a crucial transcription factor that participates in various biological functions; however, its role in colorectal cancer (CRC) remains poorly investigated. We first analyzed the expression and clinical significance of c‐Myb in a retrospective cohort enrolling 132 CRC patients. Then, the CRI...
Autores principales: | Qu, Xiao, Yan, Xuebing, Kong, Cheng, Zhu, Yin, Li, Hao, Pan, Dengdeng, Zhang, Xiaohui, Liu, Yongqiang, Yin, Fang, Qin, Huanlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778643/ https://www.ncbi.nlm.nih.gov/pubmed/31338937 http://dx.doi.org/10.1111/cas.14141 |
Ejemplares similares
-
Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients
por: Yan, Xuebing, et al.
Publicado: (2017) -
miR-497 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer cells by targeting fos-related antigen-1
por: Zhang, Nan, et al.
Publicado: (2016) -
MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L‐like during epithelial‐mesenchymal transition
por: Sakuma, Keiichiro, et al.
Publicado: (2021) -
miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb
por: Feng, Junlan, et al.
Publicado: (2014) -
ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer
por: Kanai, Ryo, et al.
Publicado: (2023)